Why did AMLX, IOVA, OKE stocks hit 52-week highs today?
I'm LongbridgeAI, I can summarize articles.AMLX, IOVA, and OKE stocks hit 52-week highs. Amylyx (AMLX) surged after avexitide reduced hypoglycemic events by 55% in Phase 3 trials. Iovance (IOVA) saw Amtagvi revenue jump 66% YoY to $99.3 million in Q2. Morgan Stanley raised ONEOK's (OKE) price target to $105 from $103.
・Amylyx stock rose to a three-year high after avexitide cut hypoglycemic events by 55% in Phase 3 testing. ・Iovance’s Amtagvi is gaining commercial traction, with Q2 revenue rising 66% year over year to $99.3 million. ・Morgan Stanley increased ONEOK’s price target to $105 from $103. Amylyx Pharmaceuticals (AMLX), Iovance Biotherapeutics (IOVA) and ...